August 2, 2021
City & State announced their Life Sciences Power 50 – and we are NOT surprised that some local Hudson Square neighbors are on the list – Congrats!!!
Read full list here.
#6 – Alex Gorsky
Board Chair + CEO, Johnson & Johnson
In 2017, the Johnson & Johnson Innovation network teamed up with the New York Genome Center on JLABS @ NYC, a 30,000-square-foot facility to house biotech startups with $17 million in funding from the state.
#8 – Robert Schneider
Associate Dean for Therapeutics Alliances, NYU Langone Health
In 2017, NYU Langone Health rolled out BioLabs@NYULangone, with space for up to 35 biotech startups. Funded by NYU Langone, the New York City Economic Development Corp.’s LifeSci NYC Initiative and Empire State Development, the incubator is a partnership with BioLabs, a national biotech network. When BioLabs@NYULangone was announced, Robert Schneider, NYU Langone Health’s associate dean for therapeutics alliances and a professor of molecular pathogenesis, touted his institution’s track record in translating biomedical innovations and drug discoveries into high-tech job growth.
#11 – Tom Manitis
Scientific Director and CEO, NY Genome Center
The New York Genome Center mobilized quickly in response to the COVID-19 pandemic. Tom Maniatis launched the COVID-19 Genomics Research Network alongside other researchers as New York became the early hotspot for COVID-19. More recently, the academic research institution has played a key role in sequencing coronavirus samples and monitoring variants. Maniatis, who’s also a Columbia University professor, has served as the genome center’s scientific director and CEO since 2017. He oversees the center’s development of genomic methods and research to better understand cancer and neurodegenerative and neuropsychiatric diseases.
#31 – Nat Turner + Zach Weinberg
Co-founders, Flatiron Health
After Nat Turner saw firsthand the challenges his cousin faced with getting cancer treatment, he was inspired to launch a new venture that would fight cancer with technology. In 2012, he and Zach Weinberg founded Flatiron Health, which gathers real-world clinical data to gather insights on effective treatments for oncologists. Turner and Weinberg stepped down from their respective positions as CEO and chief operating officer earlier this year, though Turner continues to be involved as chair of the company’s board of directors. The digital health startup’s CEO is now Carolyn Starrett.